The 1993 intercomparison of the measurement of in vivo radioactivity

Radiation Protection Dosimetry

Volumn 86, Issue 3, 1999, Pages 197-205

  Kramer, G H ^a   Loesch, R M ^b   Olsen, P C ^c  

^a HEALTH CANADA   (Canada)

^b U S DEPARTMENT OF ENERGY   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; POLYURETHAN; POTASSIUM 40; RADIOISOTOPE; YTTRIUM;

ARTICLE; DOSIMETRY; ENERGY TRANSFER; PATIENT MONITORING; PHANTOM; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; WHOLE BODY COUNTER;

EID: 0033461210     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a032943     Document Type: Article

References (7)

1. Kramer, G. H. and Limson Zamora, M. The Canadian National Calibration Reference Centre for Bioassay and In-Vivo Monitoring: A Programme Summary. Health Phys. 67(2), 192-196 (1994).
2. Kramer, G. H., Noel, L. and Burns, L. The BRMD BOMAB Phantom Family. Health Phys. 61(6), 895-902 (1991).
3. Kramer, G. H. The Canadian Whole Body Counting Intercomparison Programme: a Summary Report for 1989-1993. Health Phys. 69(4), 560-565 (1995).
4. International Commission on Radiological Protection. Reference Man: Anatomical, Physiological and Metabolic Characteristics (Oxford: Pergammon Press) ICRP Publication 23 (1975).
5. Currie, L. A. Limits for Qualitative Detection and Quantitative Determination: Application to Radiochemistry. Anal. Chem. 40(3), 586-593 (1968).
6. Brodsky, A. Accuracy and Detection Limits for Bioassay Measurements in Radiation Protection. (Washington, DC: US Nuclear Regulatory Commission) NUREG-1156 (1986).
7. Berk, K. N. and Carey, P. Data Analysis (Pacific Grove, CA: Duxbury Press) (1998).